Subscribe
Date
Past
2012
2013
2014
2015
2016
2017
2018
2019
2020
Upcoming

In this webinar ATCC expert Kevin Grady will cover these key points:

  • Toxicologists need the high biological relevance of primary cells and the proliferative capacity of cell lines for standard, predictive assays; neither model provides both characteristics.
  • upcyte® technology offers sufficient quantities of hepatocytes that exhibit primary cell physiologies such as CYP activity. Long-term culturing is possible to detect low level hepatotoxicity.
  • upcyte® Hepatocytes are fully characterized with validated performance data, and they are tested for CYP induction and inhibition.

Antimicrobial Resistance I

A Broad-spectrum Public Health Crisis

2/13/2020

This first part of a two-part webinar series on antimicrobial resistance, presented by ATCC Scientist Christine Fedorchuk, will provide these key takeaways:

  • Understanding the true burden of antimicrobial resistant infections: explaining the global prevalence and epidemiology of drug-resistant infections, breaking down morbidity and mortality of the most critical pathogens, and underlining the astronomical costs and unsustainable toll that AMR infections take.
  • Explaining how drug resistance works: demonstrating how antibiotics and other antimicrobial compounds work, the molecular mechanisms employed by AMR pathogens to evade these drugs, and how resistance continues to spread.

Antimicrobial Resistance II

Arm Your Lab in the Fight Against Superbugs

2/27/2020

This second part of a two-part webinar series on antimicrobial resistance, presented by ATCC Scientist Christine Fedorchuk, will provide these key takeaways:

  • Understanding the nature of the problem: explaining the biggest challenges hindering advancement such as financial deficits, implementation of surveillance or new therapies, and the speed of resistance outpacing the speed of scientific research.
  • Explaining progress: scientific and clinical advances, how organizations are contributing to the fight against AMR, and how ATCC is contributing to the fight against AMR.